Пожалуйста, используйте этот идентификатор, чтобы цитировать или ссылаться на этот ресурс: http://elar.urfu.ru/handle/10995/111829
Полная запись метаданных
Поле DCЗначениеЯзык
dc.contributor.authorGadelshin, V. M.en
dc.contributor.authorFormento, Cavaier, R.en
dc.contributor.authorHaddad, F.en
dc.contributor.authorHeinke, R.en
dc.contributor.authorStora, T.en
dc.contributor.authorStuder, D.en
dc.contributor.authorWeber, F.en
dc.contributor.authorWendt, K.en
dc.date.accessioned2022-05-12T08:23:46Z-
dc.date.available2022-05-12T08:23:46Z-
dc.date.issued2021-
dc.identifier.citationGadelshin V. M. Terbium Medical Radioisotope Production: Laser Resonance Ionization Scheme Development / V. M. Gadelshin, Cavaier R. Formento, F. Haddad // Frontiers in Medicine. — 2021. — Vol. 8. — 727557.en
dc.identifier.issn2296-858X-
dc.identifier.otherAll Open Access, Gold, Green3
dc.identifier.urihttp://elar.urfu.ru/handle/10995/111829-
dc.description.abstractTerbium (Tb) is a promising element for the theranostic approach in nuclear medicine. The new CERN-MEDICIS facility aims for production of its medical radioisotopes to support related R&D projects in biomedicine. The use of laser resonance ionization is essential to provide radioisotopic yields of highest quantity and quality, specifically regarding purity. This paper presents the results of preparation and characterization of a suitable two-step laser resonance ionization process for Tb. By resonance excitation via an auto-ionizing level, the high ionization efficiency of 53% was achieved. To simulate realistic production conditions for Tb radioisotopes, the influence of a surplus of Gd atoms, which is a typical target material for Tb generation, was considered, showing the necessity of radiochemical purification procedures before mass separation. Nevertheless, a 10-fold enhancement of the Tb ion beam using laser resonance ionization was observed even with Gd:Tb atomic ratio of 100:1. © Copyright © 2021 Gadelshin, Formento Cavaier, Haddad, Heinke, Stora, Studer, Weber and Wendt.en
dc.description.sponsorshipThis research project has been supported by a Marie Skłodowska-Curie Innovative Training Network Fellowship of the European Commission’s Horizon 2020 Programme under contract number 642889 MEDICIS-PROMED; by the German Federal Ministry of Education and Research under the consecutive projects 05P12UMCIA and 05P15UMCIA. It has been also partially supported by Equipex ARRONAX-Plus (ANR-11-EQPX-0004), Labex IRON (ANR-11-LABX-18-01), ISITE NExT (ANR-16-IDEX-0007).en
dc.format.mimetypeapplication/pdfen
dc.language.isoenen
dc.publisherFrontiers Media S.A.en1
dc.publisherFrontiers Media SAen
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.sourceFront. Med.2
dc.sourceFrontiers in Medicineen
dc.subjectCERN-MEDICISen
dc.subjectGADOLINIUMen
dc.subjectISOTOPE SEPARATIONen
dc.subjectLASER RESONANCE IONIZATIONen
dc.subjectRISIKO MASS SEPARATORen
dc.subjectTERBIUMen
dc.subjectTHERANOSTICSen
dc.subjectTI:SAPPHIRE LASERen
dc.subjectTANTALUMen
dc.subjectTERBIUMen
dc.subjectARTICLEen
dc.subjectATOMIC SPECTROMETRYen
dc.subjectCOMPARATIVE STUDYen
dc.subjectCONTROLLED STUDYen
dc.subjectION CURRENTen
dc.subjectIONIZATIONen
dc.subjectLASER RESONANCE IONIZATIONen
dc.subjectRADIOCHEMISTRYen
dc.subjectSURFACE PROPERTYen
dc.titleTerbium Medical Radioisotope Production: Laser Resonance Ionization Scheme Developmenten
dc.typeArticleen
dc.typeinfo:eu-repo/semantics/articleen
dc.typeinfo:eu-repo/semantics/publishedVersionen
dc.identifier.rsi47517428-
dc.identifier.doi10.3389/fmed.2021.727557-
dc.identifier.scopus85117962857-
local.contributor.employeeGadelshin, V.M., Institut für Physik, Johannes Gutenberg-Universität, Mainz, Germany, Institute of Physics and Technology, Ural Federal University, Yekaterinburg, Russian Federation; Formento Cavaier, R., Advanced Accelerator Applications, A Novartis CompanyOriggio, Italy, GIP ARRONAX, Nantes, France; Haddad, F., GIP ARRONAX, Nantes, France; Heinke, R., Institut für Physik, Johannes Gutenberg-Universität, Mainz, Germany, SY Department, CERN, Geneva, Switzerland, Institute for Nuclear and Radiation Physics, KU Leuven, Leuven, Belgium; Stora, T., SY Department, CERN, Geneva, Switzerland; Studer, D., Institut für Physik, Johannes Gutenberg-Universität, Mainz, Germany; Weber, F., Institut für Physik, Johannes Gutenberg-Universität, Mainz, Germany; Wendt, K., Institut für Physik, Johannes Gutenberg-Universität, Mainz, Germanyen
local.volume8-
dc.identifier.wos000860041600001-
local.contributor.departmentInstitut für Physik, Johannes Gutenberg-Universität, Mainz, Germany; Institute of Physics and Technology, Ural Federal University, Yekaterinburg, Russian Federation; Advanced Accelerator Applications, A Novartis CompanyOriggio, Italy; GIP ARRONAX, Nantes, France; SY Department, CERN, Geneva, Switzerland; Institute for Nuclear and Radiation Physics, KU Leuven, Leuven, Belgiumen
local.identifier.pure23972657-
local.description.order727557-
local.identifier.eid2-s2.0-85117962857-
local.fund.cordisH2020: 642889-
local.identifier.wosWOS:000860041600001-
Располагается в коллекциях:Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Файлы этого ресурса:
Файл Описание РазмерФормат 
2-s2.0-85117962857.pdf3,35 MBAdobe PDFПросмотреть/Открыть


Все ресурсы в архиве электронных ресурсов защищены авторским правом, все права сохранены.